Cargando…
Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis
BACKGROUND: VISION is a randomised, phase 4, open-label, parallel-group, multicentre study conducted in 33 centres in Japan. The aim of this study was to assess the long-term safety of vonoprazan for maintenance treatment of healed erosive oesophagitis versus lansoprazole. METHODS: Patients with end...
Autores principales: | Haruma, Ken, Kinoshita, Yoshikazu, Yao, Takashi, Kushima, Ryoji, Akiyama, Junichi, Aoyama, Nobuo, Kanoo, Tatsuhiro, Miyata, Kouji, Kusumoto, Naomi, Uemura, Naomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152792/ https://www.ncbi.nlm.nih.gov/pubmed/37127558 http://dx.doi.org/10.1186/s12876-023-02772-w |
Ejemplares similares
-
Rationale and design of the VISION study: a randomized, open-label study to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive esophagitis
por: Uemura, Naomi, et al.
Publicado: (2018) -
Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
por: Ashida, K., et al.
Publicado: (2015) -
Vonoprazan in the management of erosive oesophagitis and peptic ulcer-induced medication: a systematic review
por: Chinzon, Décio, et al.
Publicado: (2021) -
The role of vonoprazan in patients with erosive
esophagitis
por: Zhang, Mengyu, et al.
Publicado: (2022) -
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
por: Xiao, Yinglian, et al.
Publicado: (2020)